Serial analysis of gene expression in the rat striatum following methamphetamine administration

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 13-30

  Cai, Ning Sheng ^a   McCoy, Michael T ^a   Ladenheim, Bruce ^a   Lyles, Johnalyn ^a   Ali, Syed F ^b   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Carbonic anhydrase; CHOP; METH; Neurotoxicity; SAGE

Indexed keywords

BICARBONATE; BINDING PROTEIN; CAATT ENHANCER BINDING PROTEIN; CAATT ENHANCER BINDING PROTEIN HOMOLOGOUS PROTEIN; CARBONATE DEHYDRATASE; ENHANCEOSOME; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; METHAMPHETAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; GENE EXPRESSION SYSTEM; GENE LIBRARY; GENETIC TRANSCRIPTION; HOMEOSTASIS; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; RAT; SEQUENCE HOMOLOGY; SERIAL ANALYSIS OF GENE EXPRESSION; UPREGULATION;

ANIMALIA; MAMMALIA;

EID: 33749553938     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.002     Document Type: Conference Paper

References (43)

1. MATSUMOTO, T. et al. 2002. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 97: 809-817.
2. FARRELL, M. et al. 2002. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 97: 771-772.
3. CHO, A.K. et al. 2001. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39: 161-166.
4. DAVIDSON, C. et al. 2001. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36: 1-22.
5. VOLKOW, N.D. 2001. Drug abuse and mental illness: progress in understanding comorbidity. Am. J. Psychiatry 158: 1181-1183.
6. WILSON, J.M. et al. 1996. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat. Med. 2: 699-703.
7. LANGFORD, D. et al. 2003. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J. Acquir. Immune. Defic. Syndr. 34: 467-474.
8. CAPPON, G.D., C. PU & C.V. VORHEES. 2000. Time-course of methamphetamine-induced neurotoxicity in rat caudateputamen after single-dose treatment. Brain Res. 863: 106-111.
9. CARMELIET, P. et al. 1998. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490.
10. HOTCHKISS, A.J., M.E. MORGAN & J.W. GIBB. 1979. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 25: 1373-1378.
11. HOTCHKISS, A. & J.W. GIBB. 1980. Blockade of methamphetamine-induced depression of tyrosine hydroxylase by GABA transaminase inhibitors. Eur. J. Pharmacol. 66: 201-205.
12. CADET, J. et al. 1997. Effects of UV and visible radiation on DNA-final base damage. Biol. Chem. 378: 1275-1286.
13. DENG, X. et al. 2001. Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. Brain Res. Mol. Brain Res. 93: 64-69.
14. STUMM, G. et al. 1999. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 13: 1065-1072.
15. YAMAMOTO, Y. et al. 2002. Methamphetamine induces apoptosis in seminiferous tubules in male mice testis. Toxicol. Appl. Pharmacol. 178: 155-160.
16. DENG, X. & J.L. CADET. 1999. Methamphetamine administration causes overexpression of nNOS in the mouse striatum. Brain Res. 851: 254-257.
17. DENG, X. & J.L. CADET. 2000. Methamphetamine-induced apoptosis is attenuated in the striata of copper-zinc superoxide dismutase transgenic mice. Brain Res. Mol. Brain Res. 83: 121-124.
18. JAYANTHI, S. et al. 2004. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J. 18: 238-251.
19. JAYANTHI, S. et al. 2005. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 102: 868-873.
20. VELCULESCU, V.E. et al. 1995. Serial analysis of gene expression. Science 270: 484-487.
21. FUKUMURA, M. et al. 1998. A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein. Brain Res. 806: 1-7.
22. SOK, J. et al. 1999. CHOP-dependent stress-inducible expression of a novel form of carbonic anhydrase VI. Mol. Cell Biol. 19: 495-504.
23. PASTOREKOVA, S. et al. 2004. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J. Enzyme Inhib. Med. Chem. 19: 199-229.
24. LASH, A.E. et al. 2000. SAGEmap: a public gene expression resource. Genome Res. 10: 1051-1060.
25. CADET, J.L. et al. 2001. Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array. Synapse 41: 40-48.
26. THOMAS, D.M. et al. 2004. Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment-an oligonucleotide microarray approach. J. Neurochem. 88: 380-393.
27. BACKMAN, C. & M. MORALES. 2002. Acute methamphetamine administration upregulates NGFI-B mRNA expression in the striatum: co-localization with c-Fos immunoreactivity. Synapse 44: 158-165.
28. ISHIGAMI, A. et al. 2003. The application of immunohistochemical findings in the diagnosis in methamphetamine-related death-two forensic autopsy cases. J. Med. Invest. 50: 112-116.
29. CADET, J.L., M.T. MCCOY & B. LADENHEIM. 2002. Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: evidence from cDNA array analyses. Synapse 44: 211-226.
30. KUPERMAN, D.I. et al. 1997. Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat-shock protein induction. Brain Res. 771: 221-227.
31. NOAILLES, P.A. et al. 2003. Methamphetamine-induced gene expression profiles in the striatum of male rat pups exposed to the drug in utero. Brain Res. Dev. Brain Res. 147: 153-162.
32. CHEN, Q. et al. 1992. Activation of the growth arrest and DNA damage-inducible gene gadd 153 by nephrotoxic cysteine conjugates and dithiothreitol. J. Biol. Chem. 267: 8207-8212.
33. CARLSON, S.G. et al. 1993. Regulation of the C/EBP-related gene gadd153 by glucose deprivation. Mol. Cell Biol. 13: 4736-4744.
34. WANG, X.Z. et al. 1998. Identification of novel stress-induced genes downstream of chop. EMBO J. 17: 3619-3630.
35. CHO, A.K. & W.P. MELEGA. 2002. Patterns of methamphetamine abuse and their consequences. J. Addict. Dis. 21: 21-34.
36. CADET, J.L., S. JAYANTHI & X. DENG. 2003. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17: 1775-1788.
37. WILSON, J.M. et al. 1996. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology 47: 718-726.
38. FROST, D.O. & J.L. CADET. 2000. Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res. Brain Res. Rev. 34: 103-118.
39. ITZHAK, Y. et al. 2004. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice. Neuropharmacology 46: 74-84.
40. KURODA, M. et al. 1999. Induction of a secreted protein by the myxoid liposarcoma oncogene. Proc. Natl. Acad. Sci. USA 96: 5025-5030.
41. SULZER, D. & S. RAYPORT. 1990. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5: 797-808.
42. RAISANEN, S.R. et al. 1999. Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J. 13: 513-522.
43. POTTER, C. & A.L. HARRIS. 2004. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 3: 164-167.